These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11119584)

  • 1. Gps2, a protein partner for human papillomavirus E6 proteins.
    Degenhardt YY; Silverstein SJ
    J Virol; 2001 Jan; 75(1):151-60. PubMed ID: 11119584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of transcriptional regulatory properties of p53 by HPV E6.
    Crook T; Fisher C; Masterson PJ; Vousden KH
    Oncogene; 1994 Apr; 9(4):1225-30. PubMed ID: 8134125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X
    Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
    Liu X; Roberts J; Dakic A; Zhang Y; Schlegel R
    Virology; 2008 Jun; 375(2):611-23. PubMed ID: 18367227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus 16 E6 Induces FoxM1B in Oral Keratinocytes through GRHL2.
    Chen W; Shimane T; Kawano S; Alshaikh A; Kim SY; Chung SH; Kim RH; Shin KH; Walentin K; Park NH; Schmidt-Ott KM; Kang MK
    J Dent Res; 2018 Jul; 97(7):795-802. PubMed ID: 29443638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutant of human papillomavirus type 16 E6 deficient in binding alpha-helix partners displays reduced oncogenic potential in vivo.
    Nguyen M; Song S; Liem A; Androphy E; Liu Y; Lambert PF
    J Virol; 2002 Dec; 76(24):13039-48. PubMed ID: 12438630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes.
    Liu X; Han S; Baluda MA; Park NH
    Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.
    Xu M; Katzenellenbogen RA; Grandori C; Galloway DA
    J Virol; 2010 Nov; 84(21):11461-9. PubMed ID: 20739528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E6/E7 and E6
    Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
    Front Immunol; 2019; 10():1676. PubMed ID: 31396215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
    Teissier S; Pang CL; Thierry F
    Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
    Pim D; Storey A; Thomas M; Massimi P; Banks L
    Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The papillomavirus E6 proteins.
    Rapp L; Chen JJ
    Biochim Biophys Acta; 1998 Aug; 1378(1):F1-19. PubMed ID: 9739758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
    Ajiro M; Zheng ZM
    mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for novel binding proteins interacting with human papillomavirus type 18 E6 oncogene in the Hela cDNA library by yeast two-hybrid system.
    Li S; Liu P; Xi L; Jiang X; Zhou J; Wang S; Meng L; Lu Y; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):93-6. PubMed ID: 18278468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
    Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
    J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
    Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
    Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter.
    Veldman T; Liu X; Yuan H; Schlegel R
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8211-6. PubMed ID: 12821782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA.
    Bechtold V; Beard P; Raj K
    J Virol; 2003 Feb; 77(3):2021-8. PubMed ID: 12525636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
    Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
    Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.